Renal pelviceal keratinizing squamous metaplasia with sparing of pyramidal zones.Siderits RH, Fingerman J, Hazra A, Rimmer C, Colaco M, Mikhail N, Ardeleanu C, Mazari PM.
Case Rep Urol. 2012;2012:242780. Epub 2012 Jan 26
22606632
[PubMed - in process] nohighlight
Related citations Renal cell carcinoma metastasis to the paranasal sinuses and orbit.Evgeniou E, Menon KR, Jones GL, Whittet H, Williams W.
BMJ Case Rep. 2012 Mar 27;2012. pii: bcr0120125492. doi: 10.1136/bcr.01.2012.5492
22605794
[PubMed - in process] nohighlight
Related citations Tivantinib (ARQ 197), a selective inhibitor of mesenchymal-epithelial transition factor, in patients with microphthalmia transcription factor-associated tumors: Results of a multicenter phase 2 trial.Wagner AJ, Goldberg JM, Dubois SG, Choy E, Rosen L, Pappo A, Geller J, Judson I, Hogg D, Senzer N, Davis IJ, Chai F, Waghorne C, Schwartz B, Demetri GD.
Cancer. 2012 May 17. doi: 10.1002/cncr.27582. [Epub ahead of print
22605650
[PubMed - as supplied by publisher] nohighlight
Related citations Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.Klatte T, Kroeger N, Rampersaud EN, Birkhäuser FD, Logan JE, Sonn G, Riss J, Rao PN, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
Cancer. 2012 May 17. doi: 10.1002/cncr.27607. [Epub ahead of print
22605478
[PubMed - as supplied by publisher] nohighlight
Related citations Metastasis of carcinoma of the lung to a carotid body paraganglioma.Bury Y, Green R, Jain M, Moor J.
BMJ Case Rep. 2012 Apr 4;2012. pii: bcr0120125517. doi: 10.1136/bcr.01.2012.5517
22604200
[PubMed - in process] nohighlight
Related citations Vaccines for melanoma and renal cell carcinoma.Kaufman HL.
Semin Oncol. 2012 Jun;39(3):263-75
22595049
[PubMed - in process] nohighlight
Related citations Bevacizumab: overview of the literature.Braghiroli MI, Sabbaga J, Hoff PM.
Expert Rev Anticancer Ther. 2012 May;12(5):567-80
22594892
[PubMed - in process] nohighlight
Related citations Serum amyloid a: a biomarker for renal cancer.Fischer K, Theil G, Hoda R, Fornara P.
Anticancer Res. 2012 May;32(5):1801-4
22593464
[PubMed - in process] nohighlight
Related citations Presurgical Treatment with Sunitinib for Renal Cell Carcinoma with a Level III/IV Vena Cava Tumour Thrombus.Horn T, Thalgott MK, Maurer T, Hauner K, Schulz S, Fingerle A, Retz M, Gschwend JE, Kübler HR.
Anticancer Res. 2012 May;32(5):1729-35
22593453
[PubMed - in process] nohighlight
Related citations A functional polymorphism C-1310G in the promoter region of Ku70/XRCC6 is associated with risk of renal cell carcinoma.Wang W, Pan X, Huo X, Yan F, Wang M, Wang D, Gao Y, Cao Q, Luo D, Qin C, Yin C, Zhang Z.
Mol Carcinog. 2012 May 16. doi: 10.1002/mc.21914. [Epub ahead of print
22593040
[PubMed - as supplied by publisher] nohighlight
Related citations Differentiating radiological features of rapid- and slow-growing renal cell carcinoma using multidetector computed tomography.Choi SJ, Kim HS, Ahn SJ, Park Y, Choi HY.
J Comput Assist Tomogr. 2012 May;36(3):313-8
22592616
[PubMed - in process] nohighlight
Related citations Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.Shan W, Mercado-Uribe I, Zhang J, Rosen D, Zhang S, Wei J, Liu J.
Cell Cycle. 2012 Jun 1;11(11). [Epub ahead of print
22592533
[PubMed - as supplied by publisher]
Free Article nohighlight
Related citations Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies.Sejima T, Iwamoto H, Morizane S, Hinata N, Yao A, Isoyama T, Saito M, Amisaki T, Takenaka A.
Urol Oncol. 2012 May 14. [Epub ahead of print
22591748
[PubMed - as supplied by publisher] nohighlight
Related citations Angiogenetic pathway as a therapeutic target in renal cell carcinoma.Bianconi M, Scartozzi M, Faloppi L, Bittoni A, Maccaroni E, Giampieri R, Del Prete M, Burattini L, Cascinu S.
Anal Quant Cytol Histol. 2012 Feb;34(1):15-22
22590815
[PubMed - in process] nohighlight
Related citations Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation.Degraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ.
PLoS One. 2012;7(5):e36669. Epub 2012 May 10
22590586
[PubMed - in process]
Free PMC Article nohighlight
Related citations Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.Kususda Y, Miyake H, Gleave ME, Fujisawa M.
Br J Cancer. 2012 May 15. doi: 10.1038/bjc.2012.209. [Epub ahead of print
22588555
[PubMed - as supplied by publisher] nohighlight
Related citations Unraveling the role of hypoxia-inducible factor in renal cell carcinoma: a biological and therapeutic perspective.Pal SK, Figlin RA.
Cancer Discov. 2011 Aug;1(3):198-9
22586568
[PubMed - in process] nohighlight
Related citations Is there a link between the occurrence of Kidney cancer and hypertension in Tunisian population?Ferchichi I, Kourda N, Derouiche A, Baltagi S, Chebil M, Benammar-Elgaaied A.
Tunis Med. 2012 May;90(5):397-400
22585648
[PubMed - in process]
Free Article nohighlight
Related citations Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinom.Ozardili I, Guldur ME, Ciftci H, Bitiren M, Altunkol A.
Singapore Med J. 2012 May;53(5):332-5
22584974
[PubMed - in process]
Free Article nohighlight
Related citations Sunitinib-Induced Autoimmune Thyroiditis in a Patient with Metastatic Renal Cell Carcinoma: A Case Report.Babacan T, Sevinc A, Akarsu E, Balakan O.
Chemotherapy. 2012 May 12;58(2):142-145. [Epub ahead of print
22584361
[PubMed - as supplied by publisher] nohighlight
Related citations First
1
2
3
4
5
6
7
8
9
Next
Last 1503/30059
